DCGI Nods Emergency Use Of Zydus Cadila's 'Virafin' For Moderate COVID-19

The Drugs Controller General of India on April 23 approved the emergency use of Zydus Cadila's Pegylated Interferon alpha-2b (PegIFN), ‘Virafin' to treat moderately infected COVID patients. Reportedly, Zydus claims that 91.5% of patients administered with this drug have shown fast recovery while requiring less oxygen for treatment. Interestingly, they also tested negative on RT-PCR test by day 7. India recorded 3.32 lakh fresh COVID-19 cases on April 23.